Micro- and Nanotechnology related to Biological sciences
Hungarian and Israeli biotech companies teamed up to tackle Crohn’s, an intractable inflammatory bowel disease that affects five million people worldwide. Its causes are uncertain. There is no foolproof cure and poor public understanding of the pain and chronic suffering it causes. But things are looking up thanks to the work of the Eureka PIP-4-CD team.
A German engineering firm and spin-off of the University of Karlsruhe has teamed up with the Technical University of Dresden and a Greek software company to develop an innovative and commercially viable code that simulates the results of wind-induced loads on high-rises.